Swiss Re’s CVS Health CVS Stock Holding History

Swiss Re’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.5K	Hold	327	–	–	0.14%	106
2025 Q4	$26K	Buy	+327	New	+$25.8K	﹤0.01%	93

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Swiss Re's CVS Position: Q1 2026 in Review

Swiss Re held its CVS Health (CVS) position steady in Q1 2026 at 327 shares worth $23.5K. The position accounts for 0.14% of the portfolio, ranked #106.

Swiss Re first reported a position in CVS in Q4 2025 and has held it in 2 quarters since. The position peaked at $26K in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Swiss Re held 327 shares of CVS Health worth $23.5K as of Q1 2026.
Swiss Re left its CVS Health share count unchanged in Q1 2026.
CVS Health made up 0.14% of Swiss Re's portfolio in Q1 2026, its #106 holding.
Swiss Re first reported a position in CVS Health in Q4 2025 and has held it in 2 quarters since.
Swiss Re's CVS Health position peaked at $26K in Q4 2025.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Swiss Re's 13F filing for Q1 2026, filed 12 May 2026.